Invesco Ltd. Has $7.57 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Invesco Ltd. decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 83.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 398,990 shares of the medical instruments supplier's stock after selling 1,974,206 shares during the quarter. Invesco Ltd. owned approximately 0.20% of DENTSPLY SIRONA worth $7,573,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. UMB Bank n.a. lifted its stake in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares during the period. Blue Trust Inc. lifted its position in shares of DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock worth $137,000 after acquiring an additional 707 shares during the period. Federated Hermes Inc. grew its holdings in shares of DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after purchasing an additional 915 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its position in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares during the period. Finally, Riverview Trust Co acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at $26,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded up $0.12 during mid-day trading on Monday, reaching $13.87. 2,260,426 shares of the company were exchanged, compared to its average volume of 2,970,223. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $31.00. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a fifty day moving average of $15.09 and a 200 day moving average of $18.25. The stock has a market cap of $2.76 billion, a PE ratio of -6.70, a PEG ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.61%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.52% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on XRAY. Evercore ISI reissued an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Mizuho decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a report on Tuesday, April 15th. Finally, StockNews.com lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Thirteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $22.58.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.